Artia Global Partners LP / VKTX
Artia Global Partners LP’s Viking Therapeutics Inc Position
Does Artia Global Partners LP own Viking Therapeutics Inc (VKTX)? Yes — 180.7K shares worth $6M (+1.18% of its 13F portfolio) as of Q1 2026, down from 719.4K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
180.7K
% of Portfolio
+1.18%
Quarters Held
14
currently held
Position History VKTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 180.7K | $6M | +1.18% |
| Q4 2025 | 719.4K | $25M | +3.59% |
| Q3 2025 | 146.2K | $4M | +0.61% |
| Q2 2025 | 96.5K | $3M | +0.62% |
| Q1 2025 | 90.3K | $2M | +0.55% |
| Q4 2024 | 90.3K | $4M | +1.30% |
| Q3 2024 | 532.9K | $34M | +9.20% |
| Q2 2024 | 453.0K | $24M | +4.64% |
| Q1 2024 | 433.6K | $36M | +7.15% |
| Q4 2023 | 383.6K | $7M | +2.08% |
| Q3 2023 | 383.6K | $4M | +1.77% |
| Q2 2023 | 383.6K | $6M | +2.14% |
| Q1 2023 | 68.4K | $1M | +0.42% |
| Q4 2022 | 130.9K | $1M | +0.47% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of VKTX.